의료기기 이야기

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: The Role of AI in the Practice of Human Factors Engineering▶ 일시: 2024년 11월 20일 CST 9시 (한국시간: 11월 21일 00시) During this webinar, the presenters will briefly discuss the various medical technologies that incorporate AI features and/or machine learning. However, the focus will be on how AI of the chatbot variety can facilitate a wide range of analyses and writing eff..

SummaryOn October 24, 2024, the U.S. Food and Drug Administration (FDA) will host a webinar for laboratory manufacturers and other interested parties to discuss the FDA’s Total Product Life Cycle (TPLC) approach to the oversight of in vitro diagnostic products (IVDs). The FDA’s TPLC approach allows the FDA to review and monitor medical devices throughout their life cycle by taking into account a..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Regulation (EU) 2024/1860 and IVDR Compliance in Europe▶ 일시: 2024년 10월 16일 CST 9시 (한국시간: 10월 16일 23시)  Are you an IVD medical device manufacturer who needs a better understanding of what action you will need to take and when so that you can make use of the extension under the revised Regulation (EU) 2024/1860. The European Commission amended the In Vitro Diagnost..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Importer/Distributor MDR Requirements and Impacts for Manufacturers▶ 일시: 2024년 09월 11일 CST 09시 (한국시간: 09월 11일 23시)  Economic Operator (EO) is a term not identified in the Medical Devices Directive 93/42/EEC (MDD). The Medical Devices Regulation (EU) 2017/745 (MDR) defines in Article 2 what an EO is. There are four types of entities/organizations: manufacturer, au..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Open Forum: Human Factors Usability Testing Q&A▶ 일시: 2024년 08월 22일 CST 9시 (한국시간: 08월 22일 23시)  Usability testing is one of the most important activities you can perform during the development of your medical device. Usability testing results can help you determine user needs, better understand use-related risks, inform your design process, and demonstrate safer a..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Japan Regulatory Requirements - Medical Device Software▶ 일시: 2024년 08월 08일 CST 9시 (한국시간: 08월 08일 23시) As the global market for medical device software (SaMD) expands, navigating the regulatory landscape becomes increasingly critical for manufacturers. While many regions share similar regulatory approaches, Japan presents unique challenges and opportunities. Our u..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Best Practices for Engaging with the US FDA on Human Factors Strategy▶ 일시: 2024년 07월 11일 EST 10시 (한국시간: 07월 11일 23시)  Engaging with the U.S. Food and Drug Administration (FDA) on your human factors engineering (HFE) strategy is an important step toward achieving a successful medical product submission and subsequent U.S. market access. In this webinar, the presen..

SummaryOn July 16, 2024, the U.S. Food and Drug Administration (FDA) will host a webinar to discuss how in vitro diagnostic products (IVDs) are classified by the FDA.  If you have questions that you wish to submit for possible discussion during the webinar, please email CDRHWebinars@fda.hhs.gov. All questions must be received by June 28, 2024, to be considered for the discussion. Questions will ..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Medical Device Software and Cybersecurity▶ 일시: 2024년 05월 14일 CST 10시 (한국시간: 05월 14일 23시)  As medical devices become more and more interconnected — and the applications of medical device software grow exponentially — there is a need to ensure that these devices, when placed on the market, are safe and effective and remain in this state throughout their lifetime. I..

Emergo에서 아래와 같이 웨비나를 개최한다.​▶ 주제: Revised IVD Regulation RDC 830/2023▶ 일시: 2024년 04월 30일 CST 9시 (한국시간: 04월 30일 23시)  The ANVISA – Agência Nacional de Vigilância Sanitária  issued Resolution RDC No. 830/2023, on Dec. 11, 2023. The resolution is intended to help IVD medical device manufacturers determine what information is required in a registration submission. The Resolution outlines a new ..